Neuroimmunology and Neuroinfectious Diseases

This session focuses on newly identified viral infections of the nervous system, emphasizing their pathogenesis, epidemiology, and clinical implications. Researchers are encouraged to present data on emerging neuroinfectious threats and potential therapeutic approaches. Attendees will gain a comprehensive understanding of the challenges posed by these infections and the latest advancements in combating them.

This track seeks research exploring the role of autoimmunity in neurodegenerative diseases such as multiple sclerosis and beyond. Submissions should highlight new biomarkers, diagnostic tools, and therapeutic strategies. Attendees will discover the latest insights into how autoimmunity contributes to neurodegeneration and potential interventions to mitigate these effects.

This session invites abstracts investigating the link between neuroinflammation and psychiatric disorders, including depression and schizophrenia. Researchers should focus on the inflammatory processes that contribute to the pathophysiology of mental health conditions. Attendees can expect to learn about innovative approaches to diagnosing and treating these disorders through the lens of neuroimmunology.

This track will showcase cutting-edge advancements in immunotherapy for treating neuroimmune disorders. Researchers are encouraged to submit abstracts on novel immunotherapeutic agents, mechanisms of action, and clinical trial outcomes. Attendees will gain a deep understanding of the potential of immunotherapy to revolutionize the treatment of neuroimmune diseases.

Focusing on the role of microglia in neuroimmune processes, this session invites research on their involvement in both neuroprotection and neurodegeneration. Researchers should present findings on microglial activity in various neuroimmune contexts. Attendees will learn about emerging therapeutic targets and strategies aimed at modulating microglial function to treat neuroimmune disorders.

This track welcomes research on the global and regional epidemiology of neuroinfectious diseases. Abstracts should address current trends, risk factors, and public health implications of these diseases. Attendees will gain valuable insights into the epidemiological patterns of neuroinfectious diseases and strategies for effective prevention and control.

Researchers are invited to submit studies on the molecular and cellular pathways involved in neuroimmune disorders. This session will highlight new mechanisms underlying neuroimmune interactions and potential therapeutic targets. Attendees will benefit from a detailed understanding of the molecular underpinnings of neuroimmune diseases and how these insights can lead to innovative treatments.

This session invites research on the blood-brain barrier (BBB) and its role in neuroimmunology, focusing on its dysfunction in disease and advancements in drug delivery across the BBB. Researchers should present findings on how the BBB impacts neuroimmune processes and therapeutic outcomes. Attendees will gain insights into novel approaches to targeting the BBB in treating neuroimmune disorders.

Explore how genomic data and precision medicine are reshaping neuroimmunology. This track invites abstracts that demonstrate the application of genomics in diagnosing and treating neuroimmune diseases. Attendees will learn about cutting-edge research in precision medicine and its potential to revolutionize personalized treatment approaches for neuroimmune disorders.

This track invites research on the discovery and validation of biomarkers for neuroimmune disorders. Researchers should present studies that link biomarkers to early detection, disease monitoring, and treatment responses. Attendees will gain a comprehensive understanding of how biomarkers are transforming clinical practice and research in neuroimmunology.

This session focuses on the role of innate immune responses in neurological disorders. Researchers are encouraged to submit abstracts on how these immune mechanisms contribute to disease progression and therapeutic potential. Attendees will gain insights into the emerging role of innate immunity in neuroimmune diseases and novel strategies for therapeutic intervention.

This track explores the impact of the gut microbiome on neuroimmune interactions, delving into the gut-brain axis. Researchers are invited to present findings on how microbiota influence neuroimmune function and contribute to neurological diseases. Attendees will gain insights into the therapeutic potential of modulating the microbiome to treat neuroimmune disorders.

This session invites research at the intersection of immune function and metabolism, focusing on how metabolic pathways influence neuroinflammatory diseases. Researchers should present findings on the role of immunometabolism in disease progression and treatment. Attendees will learn about emerging therapeutic targets that bridge immunology and metabolism in neuroinflammatory disorders.

This track seeks abstracts on how environmental factors, such as toxins, infections, and pollutants, trigger neuroimmune responses and contribute to neurological diseases. Researchers should present data on the mechanistic pathways involved and potential interventions. Attendees will gain insights into the role of environmental factors in neuroimmune diseases and strategies for mitigating their impact.

Researchers are invited to submit work on the neuroimmune mechanisms underlying pain and neuropathic conditions. This session will provide insights into the latest research on how immune responses contribute to chronic pain and potential therapeutic strategies for managing pain through neuroimmune modulation. Attendees will learn about cutting-edge approaches to treating neuropathic pain.

This session will highlight cutting-edge research on cellular and molecular immunotherapy approaches for neuroinfectious diseases. Researchers are encouraged to submit abstracts on novel therapies, mechanisms of action, and clinical outcomes. Attendees will gain a deep understanding of the potential of immunotherapy to transform the treatment landscape for neuroinfectious diseases.

This track invites research on the role of neuroimmune processes in aging and age-related neurodegenerative diseases. Researchers should present findings on how immune responses contribute to neurodegeneration and potential interventions to slow or reverse these effects. Attendees will gain insights into the interplay between aging, neuroimmunity, and neurodegeneration, with a focus on innovative therapeutic strategies.

Focusing on the application of CRISPR and other gene-editing technologies, this session invites research on their potential to treat neuroimmune disorders. Researchers should present studies on the ethical, practical, and therapeutic implications of gene editing in neuroimmunology. Attendees will explore the transformative potential of gene editing in treating complex neuroimmune diseases.

This track will showcase the integration of AI and machine learning in neuroimmunology research. Researchers are encouraged to submit abstracts on how these technologies are advancing the understanding, diagnosis, and treatment of neuroimmune diseases. Attendees will learn about the latest AI-driven approaches that are shaping the future of neuroimmunology and offering new avenues for research and clinical application.